card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab

Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab
Home / Insights / Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab

In the June issue of Contract Pharma, IQVIA Laboratories' Chief Scientific Officer Patrice Hugo discusses the breadth of new tech-enabled analytical laboratory techniques that are making an impact in end-to-end complex drug development. This includes everything from advanced flow cytometry to high-resolution mass spectrometry and in-depth RNA/DNA sequencing. 

In this feature article, Dr. Hugo provides the "why" behind the excitement among lab specialists for transformative analytical advances. He also emphasizes the importance of what underpins the use of these solutions to effectively meet the demands of today's clinical trials, including deep expertise, operational consistencies among lab sites for data comparability, therapeutic considerations and more.  

Click here to read the full article.